Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Xin-Yan Pan"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/a65c494f3a9047cbb7c93375bba52ce0
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background We prepared an anti-p21Ras scFv which could specifically bind with mutant and wild-type p21Ras. However, it cannot penetrate the cell membrane, which prevents it from binding to p21Ras in the cytoplasm. Here, the RGD4C peptide was
Externí odkaz:
https://doaj.org/article/3aae4cb884934f73bf6fbbb9a73aa83c
Publikováno v:
Mathematical Biosciences and Engineering, Vol 16, Iss 5, Pp 4607-4621 (2019)
Objective To explore the potential mechanism which miR-527 targeting the heparan sulfate 6-O-endosulfatase (SULF2) regulates TGF-β/SMAD signaling pathway induced epithelial-mesenchymal transition (EMT) in non-small-cell lung cancer (NSCLC). Methods
Externí odkaz:
https://doaj.org/article/63c3b9b7cf65441dab0d3a44883df4af
Autor:
Fang-Rui Liu, Shuang Bai, Qiang Feng, Xin-Yan Pan, Shu-Ling Song, Hong Fang, Jing Cui, Ju-Lun Yang
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Colorectal cancer (CRC) is the most common type of gastrointestinal cancer. CRC gene therapy mediated by adenovirus holds great promise for the treatment of malignancies. However, intravenous delivery of adenovirus exhibits limite
Externí odkaz:
https://doaj.org/article/7e264a4491fc43fab5d1ca87214e6e72
Publikováno v:
Anti-Cancer Drugs
Activatable cell-penetrating peptide (ACPP) is a tumour-targeting cell-penetrating peptide. Here, we used ACPP to carry anti-p21Ras scFv for Ras-driven cancer therapy. The ACPP-p21Ras scFv fusion protein was prepared by a prokaryotic expression syste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a185892202030964525b95c34d7890a
https://doi.org/10.1097/cad.0000000000001180
https://doi.org/10.1097/cad.0000000000001180
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Cancer
BMC Cancer
We prepared an anti-p21Ras scFv which could specifically bind with mutant and wild-type p21Ras. However, it cannot penetrate the cell membrane, which prevents it from binding to p21Ras in the cytoplasm. Here, the RGD4C peptide was used to mediate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf1a4c441e35b532147f40aa0137325
https://doaj.org/article/a65c494f3a9047cbb7c93375bba52ce0
https://doaj.org/article/a65c494f3a9047cbb7c93375bba52ce0
Publikováno v:
Journal of Cancer
Background: Oncolytic adenovirus-mediated gene therapy is an emerging strategy for cancer treatment. However, oncolytic adenoviruses are mainly administered locally at tumor site. Intravenous administration of oncolytic adenovirus for cancer gene the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05cc9551645b6d0a491d15042e9d1ebe
http://europepmc.org/articles/PMC8040716
http://europepmc.org/articles/PMC8040716
Publikováno v:
Immunotherapy. 12:879-890
Aim: Previously, we constructed a novel anti-p21Ras single-chain antibody fragment, KGH-R1-single-chain fragment variant (ScFv). However, the immunoreactivity of this antibody toward p21Ras is still unclear. Materials & methods: ELISAs, immunohistoch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4f5940aed2d8aba7e0343e94d6a23c
https://doi.org/10.2217/imt-2019-0222
https://doi.org/10.2217/imt-2019-0222
Publikováno v:
World Journal of Clinical Cases
Background Multiple endocrine neoplasia type 1 (MEN1) is a rare hereditary disorder caused by mutations of the MEN1 gene. It is characterized by hyperparathyroidism and involves the pancreas, anterior pituitary, duodenum, and adrenal gland. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d8e4df8a4536620cdcd18b6156dc8a
https://doi.org/10.12998/wjcc.v8.i12.2647
https://doi.org/10.12998/wjcc.v8.i12.2647
Background Extra nodal NK/T cell lymphoma (ENKTL) is rarely occurred in the gallbladder, and it is generally difficult to diagnose before surgery. Here we present a case of primary ENKTL of gallbladder. Case presentation A 61-year-old female with pai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cfd372d1ef86bf3a5c4bded250ef6cf
https://doi.org/10.21203/rs.3.rs-801081/v1
https://doi.org/10.21203/rs.3.rs-801081/v1
